Related Experiment Video
Updated: Dec 12, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Pharmacoprevention of Human Immunodeficiency Virus Infection
Charles Yingling1, Cindy Broholm2, Shirley Stephenson3
1Department of Population Health Nursing Science, University of Illinois at Chicago College of Nursing, 845 South Damen Avenue, Chicago, IL 60612, USA.
Abstract:
This article reviews the disparities in human immunodeficiency virus (HIV) incidence, presents evidence on the efficacy of preexposure prophylaxis (PrEP) and nonoccupational postexposure prophylaxis (nPEP), provides an overview of clinical guidelines for prescribing PrEP and nPEP, discusses strategies to promote efficient use of these effective interventions, and reviews best practices in treatment retention for people at high risk for HIV. Nurses are optimally positioned to prevent new HIV infections. When working with sensitive topics such as sexual practices and substance use, nurses excel at building rapport, making shared decisions, and educating about risk reduction with an affirming, nonjudgmental approach.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics: Drug–Food and Drug–Viral Interactions

